How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recent insider activity for Recursion Pharmaceuticals Inc consisted of 1 transaction totaling $18,400.36. The transaction was a Tax Payment by Ben R Taylor, the company’s Chief Financial Officer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results